Dyspnea, Risk of Falling and Quality of Life in Adolescents, Youth and Geriatric Groups

March 4, 2024 updated by: Amira Hussin Hussin Mohammed
To assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics.

Study Overview

Status

Completed

Conditions

Detailed Description

An observational study was done to assess the correlation between aspects of the dyspnea scale (indicating poor functionality), the fall efficacy scale (indicating a higher fear of falling), and all aspects of the SF36 (indicating quality of life) in 3 age groups: adolescents, youth, and geriatrics. The participants in each group were assessed using the previously mentioned scales. Then the relationships between them were calculated and analyzed.

Study Type

Observational

Enrollment (Actual)

604

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gamasa, Egypt, 35712
        • Amira Hussin Mohammed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

All subjects were recruited from inhabitants of urban and rural areas in the Nile Delta Region, Egypt. They were assigned into 3 age-difference groups (adolescents, youth, and geriatrics).

Description

Inclusion Criteria:

The participants were male or female community-dwellers, They ranged in age: adolescents from 12 to 17 years old, youth from 20 to 22 years old, and geriatrics from 60 to 80 years old.

Exclusion Criteria:

subjects with mobility disabilities and severe cognitive impairments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
adolescents
from both sex, age ranged from twelve to seventeen years old, free from mobility disability and Severe cognitive impairment
youth
from both sex, age ranged from twenty to twenty-two years old, free from mobility disability and Severe cognitive impairment
geriatrics
from both sex, age ranged from sixty to eighty years old, free from mobility disability and Severe cognitive impairment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the severity of dyspnea
Time Frame: At the baseline evaluation
Using a dyspnea 12 (D-12) questionnaire that assesses the severity of dyspnea using a rubric of the physical and emotional aspects of dyspnea.
At the baseline evaluation
the level of fear of falling through daily life activities
Time Frame: At the baseline evaluation
Using Fall efficacy scale (FES-I) questionnaire that assesses the level of fear of falling through daily life activities
At the baseline evaluation
quality of life and public health
Time Frame: At the baseline evaluation
Using the Short Form 36 (SF-36) questionnaire. The questionnaire was assigned to eight domains: physical functioning, role-functioning, bodily pain, general health, vitality, social functioning, and role-emotional and mental health
At the baseline evaluation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2022

Primary Completion (Actual)

January 31, 2024

Study Completion (Actual)

January 31, 2024

Study Registration Dates

First Submitted

February 27, 2024

First Submitted That Met QC Criteria

March 4, 2024

First Posted (Actual)

March 12, 2024

Study Record Updates

Last Update Posted (Actual)

March 12, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Quality of life

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe